NCT Number: NCT02946476
Prognostic Impact of Noncardiac Comorbidities in Heart Failure Patients
To better understand the public health prognostic impact of noncardiac chronic illnesses, we explored the attributable risk of noncardiac comorbidities on outcomes between heart failure patients with reduced ejection fraction (HFREF) and heart failure patients with preserved ejection fraction (HFpEF) in a large contemporary heart failure (HF) population The adjusted hazard ratio (HR) and the population attributable risk were used to compare the contributions of 15 noncardiac comorbidities to adverse outcome. The comorbidities that contributed to high attributable risk were: anemia, chronic kidney disease, chronic obstructive pulmonary disease, diabetes mellitus, and peripheral artery disease. These findings were similar for HFrEF and HFpEF groups. Interaction analysis confirmed similar results.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All consecutive heart failure patients with left ventricular ejction fraction available before or within 3 months from the index visit
Exclusion criteria
- We excluded all patients who had severe primary left-sided valvular disease
Treatment and study plan
Primary outcomes
-
overall mortality
Time frame: 2 years
Secondary outcomes
-
First all-cause hospitalization
Time frame: 2 years
-
Heart Failure hospitalization
Time frame: 2 years
-
noncardiovascular hospitalization
Time frame: 2 years
Sponsors and collaborators
Lead sponsor
Ospedale Maggiore Di Trieste
Other
Registry information
Official study title
Prevalence and Prognostic Impact of Noncardiac Comorbidities in Heart Failure Outpatients With Preserved and Reduced Ejection Fraction: A Community-Based Study
Acronym: NCC-HF
Important dates
- Study start
- 2009
- Primary completion
- 2013
- Study completion
- 2014
- First posted
- Oct 27, 2016
- Registry last updated
- Oct 27, 2016
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Pilot Study Lp299v Supplementation in Chronic Heart Failure
NCT05752760
Cardiovascular Diseases, Heart Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsPredicting Heart Failure Outcomes With Biomarkers and Imaging
NCT07332520
Cardiovascular Diseases, Heart Diseases
View Trial DetailsHemodynamic-GUIDEd Management of Heart Failure
NCT03387813
Cardiovascular Diseases, Heart Diseases
Phoenix, Arizona, United States
View Trial DetailsThe Aortix CRS Pilot Study
NCT04145635
Cardio-Renal Syndrome, Cardiorenal Syndrome
Los Angeles, California, United States
View Trial Details